bromocriptine has been researched along with Prostatic Neoplasms in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (73.91) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Du, Y; Fu, H; Kavuri, S; Kucuk, O; Li, X; Mamouni, K; Wu, D; Yang, Y | 1 |
| Freudenberg, JM; Fullenkamp, AN; Ho, SM; Medvedovic, M; Szeto, CY; Tam, NN | 1 |
| Altwein, JE; Hohenfellner, R; Jacobi, GH | 2 |
| Ausfeld, R; Del Pozo, E; Huber, P | 1 |
| Altwein, JE; Faul, P | 1 |
| Baranowska, B; Jeske, W; Szymanowski, J | 1 |
| Jeromin, L | 2 |
| Chisholm, GD; Elton, RA; Habib, FK; Halliday, P; Rana, A; Ross, M; Wild, R | 1 |
| Altwein, JE; Jacobi, GH | 2 |
| Altwein, JE; Jacobi, GH; Kurth, KH | 1 |
| Altwein, JE; Jacobi, GH; Kurth, KH; Sinterhauf, K | 2 |
| Schmidt, JD | 1 |
| Huhtaniemi, I; Parvinen, M; Rannikko, S; Venho, P | 1 |
| Boucher, H; Cusan, L; Dupont, A; Emond, J; Labrie, F; Lacourciere, Y | 1 |
| Fujimoto, NA; Ito, A; Ito, N; Nakamura, A; Ogawa, K; Shirai, T; Wada, S | 1 |
| Akdaş, A; Kirkali, Z; Taşar, C | 1 |
| Hofmann, W; Langkopf, B | 1 |
| Borkiewicz, J; Janiak, Z; Jeromin, L; Rozniecki, M; Wiśniewski, J | 1 |
| Ip, MM; Sylvester, PW | 1 |
3 review(s) available for bromocriptine and Prostatic Neoplasms
| Article | Year |
|---|---|
[Advanced prostatic cancer: therapeutic modalities].
Topics: Acid Phosphatase; Antineoplastic Agents; Bromocriptine; Castration; Combined Modality Therapy; Cyproterone; Estramustine; Estrogens; Fluorouracil; Humans; Lisuride; Male; Neoplasm Metastasis; Prostatic Neoplasms; Random Allocation | 1984 |
[Bromocriptine, a new therapeutic principle in prostatic adenoma and carcinoma. Basis, possibilities, limits].
Topics: Bromocriptine; Carcinoma; Humans; Male; Nausea; Prolactin; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Cell Surface; Testosterone; Vomiting | 1978 |
Chemotherapy of prostatic cancer.
Topics: Aged; Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Bromocriptine; Cyproterone; Depression, Chemical; Diethylstilbestrol; Drug Therapy, Combination; Estramustine; Fluorouracil; Flutamide; Health Facilities; Hematologic Diseases; Humans; Kinetics; Male; Mitosis; Nitrogen Mustard Compounds; Prostatic Neoplasms | 1975 |
3 trial(s) available for bromocriptine and Prostatic Neoplasms
| Article | Year |
|---|---|
[Value of palliative treatment of metastasizing prostatic cancer with the prolactin inhibitor parlodel].
Topics: Bromocriptine; Clinical Trials as Topic; Double-Blind Method; Humans; Male; Neoplasm Metastasis; Palliative Care; Prolactin; Prostatic Neoplasms; Random Allocation | 1982 |
A case for synchronous reduction of testicular androgen, adrenal androgen and prolactin for the treatment of advanced carcinoma of the prostate.
Topics: Androgen Antagonists; Androstenedione; Bromocriptine; Humans; Hydrocortisone; Male; Orchiectomy; Prolactin; Prospective Studies; Prostatic Neoplasms; Treatment Outcome | 1995 |
[Bromocriptine for palliation of advanced prostatic carcinoma. Experimental and clinical profile of a drug (author's' transl)].
Topics: Adenocarcinoma; Aged; Androgens; Bromocriptine; Clinical Trials as Topic; Cyproterone; Humans; Male; Middle Aged; Palliative Care; Prolactin; Prostate; Prostatic Neoplasms; Testosterone | 1979 |
17 other study(ies) available for bromocriptine and Prostatic Neoplasms
| Article | Year |
|---|---|
Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bromocriptine; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Docetaxel; Dopamine Agonists; Drug Repositioning; Drug Synergism; Humans; Male; Mice, Nude; Prostatic Neoplasms; Receptors, Dopamine D2; Xenograft Model Antitumor Assays | 2018 |
Research resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia.
Topics: Animals; Bromocriptine; Calgranulin B; Cell Proliferation; Chemokine CXCL13; Epithelial Cells; Estradiol; Fulvestrant; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Interleukin-1beta; Male; Prolactin; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Rats; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Testosterone | 2010 |
Adjunct bromocriptine treatment as palliation for prostate cancer: experimental and clinical evaluation.
Topics: Bromocriptine; Hormones; Humans; Male; Pain; Palliative Care; Prostatic Neoplasms | 1980 |
[Effect of bromocriptine on prolactin secretion after dopaminergic receptor blockade with metoclopramide in patients with prostatic cancer treated with estrogens].
Topics: Aged; Bromocriptine; Diethylstilbestrol; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Metoclopramide; Middle Aged; Prolactin; Prostatic Neoplasms; Receptors, Dopamine | 1984 |
The serum levels of testosterone and prolactin in patients with prostatic carcinoma treated with various doses of Fostrolin and bromocriptin.
Topics: Antineoplastic Agents; Bromocriptine; Diethylstilbestrol; Drug Therapy, Combination; Humans; Male; Prolactin; Prostatic Neoplasms; Testosterone | 1982 |
[Treatment of prostatic carcinoma with phostrolin and bromocriptine while monitoring serum concentrations of testosterone and prolactin].
Topics: Bromocriptine; Humans; Male; Monitoring, Physiologic; Prolactin; Prostatic Neoplasms; Testosterone | 1980 |
[Bromocriptine and prostatic carcinoma: testosterone metabolism in relation to tumor grading (author's transl)].
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Androgens; Androstane-3,17-diol; Bromocriptine; Dihydrotestosterone; Humans; Male; Prostatic Neoplasms; Testosterone | 1979 |
Bromocriptine and prostatic carcinoma: plasma kinetics, production and tissue uptake of 3H-testosterone in vivo.
Topics: Aged; Biopsy, Needle; Bromocriptine; Follicle Stimulating Hormone; Humans; Kinetics; Luteinizing Hormone; Male; Prolactin; Prostatic Neoplasms; Testosterone | 1978 |
Testosterone metabolism in patients with advanced carcinoma of the prostate: a comparative in vivo study of the effects of oestrogen and antiprolactin.
Topics: Bromocriptine; Dose-Response Relationship, Drug; Estradiol; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Prolactin; Prostatic Neoplasms; Receptors, Androgen; Testosterone | 1978 |
Alterations of peripheral testosterone matabolism after induced hypoprolactinemia in patients with prostatic carcinoma.
Topics: Aged; Bromocriptine; Deficiency Diseases; Humans; Male; Prolactin; Prostatic Neoplasms; Testosterone | 1979 |
Combination of a GnRH agonist with an antiandrogen or bromocriptine in the treatment of prostatic cancer; slight potentiation of antigonadal effects.
Topics: Adult; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Buserelin; Cyproterone; Cyproterone Acetate; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Radioimmunoassay; Receptors, Gonadotropin; Testis; Testosterone | 1991 |
Octreotide and bromocriptine in patients with stage D2 prostate cancer who relapsed during treatment with flutamide and castration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Humans; Male; Octreotide; Prostatic Neoplasms | 1990 |
Promoting action of prolactin released from a grafted transplantable pituitary tumor (MtT/F84) on rat prostate carcinogenesis.
Topics: Aminobiphenyl Compounds; Animals; Bromocriptine; Carcinogens; Carcinoma; Cocarcinogenesis; Male; Neoplasm Metastasis; Neoplasm Transplantation; Organ Size; Pituitary Neoplasms; Precancerous Conditions; Prolactin; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred F344; Seminal Vesicles | 1990 |
The effect of ergobromocriptine on serum testosterone and prolactin levels in patients with carcinoma of the prostate.
Topics: Adult; Aged; Bromocriptine; Carcinoma; Humans; Male; Middle Aged; Prolactin; Prostatic Hyperplasia; Prostatic Neoplasms; Testosterone | 1986 |
[Chemotherapy of advanced prostate cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cyproterone; Cyproterone Acetate; Fluorouracil; Humans; Male; Methotrexate; Neoplasm Staging; Orchiectomy; Prognosis; Prostatic Neoplasms | 1986 |
Five-year clinical follow-up of prostatic cancer patients treated with fosfestrol and bromocriptine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Diethylstilbestrol; Follow-Up Studies; Humans; Male; Prostatic Neoplasms | 1987 |
Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
Topics: Adenocarcinoma; Animals; Bromocriptine; Cell Line; Drug Therapy, Combination; Haloperidol; Male; Neoplasm Transplantation; Orchiectomy; Prolactin; Prostatic Neoplasms; Rats; Tamoxifen; Testosterone | 1987 |